[Federal Register Volume 65, Number 33 (Thursday, February 17, 2000)]
[Notices]
[Page 8207]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-3732]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on November 29, 1999, Noramco of 
Delaware, Inc., Division of McNeilab, Inc., 500 Old Swedes Landing 
Road, Wilmington, Delaware 19801, made application by renewal to the 
Drug Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                            Drug                               Schedule
------------------------------------------------------------------------
Codeine (9050)..............................................         II
Oxycodone (9143)............................................         II
Hydrocodone (9193)..........................................         II
Morphine (9300).............................................         II
Thebaine (9333).............................................         II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances for 
distribution to its customers as bulk product.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than April 17, 2000.

    Dated: February 10, 2000.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 00-3732 Filed 2-16-00; 8:45 am]
BILLING CODE 4410-09-M